PICO Portalanswers from OpenAlex & ORCID
Lori J. Wirth
ResearcherPublications, citations & collaboration network
Lori J. Wirth is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Lori J. Wirth have?
PICO Portalindexed works
Lori J. Wirth has 583 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lori J. Wirth have?
PICO Portalcitation count
Lori J. Wirth has 20,570 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Lori J. Wirth?
PICO Portalh-index
Lori J. Wirth has an h-index of 69 in OpenAlex.
What is the i10-index of Lori J. Wirth?
PICO Portali10-index
Lori J. Wirth has an i10-index of 198 in OpenAlex.
What is the ORCID of Lori J. Wirth?
PICO Portalorcid
The ORCID for Lori J. Wirth is on the source record.
What is the OpenAlex record for Lori J. Wirth?
PICO Portalopenalex
The OpenAlex for Lori J. Wirth is on the source record.
What are the most-cited papers on Lori J. Wirth?
PICO Portalmost cited works
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger, Makoto Tahara, Lori J. Wirth, Bruce Robinson, Marcia S. Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H. Shah, Ana O. Hoff, Andrew G. Gianoukakis, Naomi Kiyota, Matthew H. Taylor, Sung‐Bae Kim, Monika K. Krzyzanowska, Corina E. Dutcus, Begoña de las Heras, Junming Zhu, Steven I. Sherman
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
Lori J. Wirth, Eric J. Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen H. Lorch, Francis P. Worden, Marcia S. Brose, Jyoti D. Patel, Sophie Leboulleux, Yann Godbert, Fabrice Barlési, John C. Morris, Taofeek K. Owonikoko, Daniel S.W. Tan, Oliver Gautschi, Jared Weiss, Christelle de la Fouchardière, Mark E. Burkard, Janessa Laskin, Matthew H. Taylor, Matthias Kroiß, Jacques Médioni, Jonathan W. Goldman, Todd M. Bauer, Benjamin Levy, Viola W. Zhu, Nehal J. Lakhani, Víctor Moreno, Kevin Ebata, Michele Nguyen, Dana Heirich, Edward Y. Zhu, Xin Huang, Luxi Yang, Jennifer Kherani, S. Michael Rothenberg, Alexander Drilon, Vivek Subbiah, Manisha H. Shah, Maria E. Cabanillas
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister, Francis P. Worden, Stephen V. Liu, Jill Gilbert, Nabil F. Saba, Jared Weiss, Lori J. Wirth, Ammar Sukari, Hyunseok Kang, Michael K. Gibson, Erminia Massarelli, Steven Powell, Amy Meister, Xinxin Shu, Jonathan D. Cheng, Robert I. Haddad
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma
Raj K. Gopal, Kirsten Kübler, Sarah E. Calvo, Paz Polak, Dimitri Livitz, Daniel Rosebrock, Peter M. Sadow, Braidie Campbell, Samuel E. Donovan, Salma Amin, Benjamin J. Gigliotti, Zenon Grabarek, Julian M. Hess, Chip Stewart, Lior Z. Braunstein, Peter F. Arndt, Scott Mordecai, Angela Shih, Frances Cháves, Tiannan Zhan, Carrie C. Lubitz, Jiwoong Kim, A. John Iafrate, Lori J. Wirth, Sareh Parangi, Ignaty Leshchiner, Gilbert H. Daniels, Vamsi K. Mootha, Dora Dias‐Santagata, Gad Getz, David G. McFadden